Participate Today
Save Lives Tomorrow!

Featured Study

EBV Vaccine Trial

FOMAT is enrolling participants for EBV Vaccine Trial.

This Clinical Trial is being conducted to evaluate an investigational vaccine in participants from 18 to 30 years old during 18 months; in pursuit of a preventive method against Epstein-Barr Virus (EBV). Currently, there’s no vaccine for EBV.

Epstein-Barr Virus (EBV) is a human herpes virus, one of the most common human viruses which causes Infectious Mononucleosis, commonly known as “Mono”. It has also been linked to many other diseases.

01 Fomat_Logo_Website-min

Which Clinical Trial Do You Want To Participate In?

Active Studies

COVID-19 Study

Healthy Volunteers

RSV Vaccines

Colorectal Cancer 

Prostate Cancer

Crohn’s Disease

 

Pediatric COVID-19 Study

Pancreatitis

Nephropathy (IgA)

C. diff 

Inflammatory Bowel Disease

Atopic Dermatitis 

Pneumococcal Vaccination

Ulcerative Colitis 

EBV 

Upcoming Studies

NASH

Pediatric Meningitis Vaccine 

Overactive Bladder 

Get Paid to be part of Advancing Research! ​


    FOMAT animated scientist
    Web-2

    What Are Clinical Trials And Are They Safe?